Enke Baldini

Pubblicazioni

Titolo Pubblicato in Anno
The role of microRNAs in different types of thyroid carcinoma. A comprehensive analysis to find new miRNA supplementary therapies JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2018
Nodular thyroid disease in the elderly. Novel molecular approaches for the diagnosis of malignancy AGING CLINICAL AND EXPERIMENTAL RESEARCH 2017
Deregulated expression of VHL mRNA variants in papillary thyroid cancer MOLECULAR AND CELLULAR ENDOCRINOLOGY 2017
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer INTERNATIONAL JOURNAL OF ONCOLOGY 2017
New perspectives in the diagnosis of thyroid follicular lesions INTERNATIONAL JOURNAL OF SURGERY 2017
Novel treatment options for anaplastic thyroid cancer EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM 2017
Dysregulation of MicroRNA biogenesis in diabetic skin Journal of investigative DermatologyJOURNAL OF INVESTIGATIVE DERMATOLOGY 2017
Thyroid hormone-regulated molecular mechanisms driving mouse blastocyst implantation EUROPEAN JOURNAL OF HISTOCHEMISTRYEUROPEAN JOURNAL OF HISTOCHEMISTRY 2017
Vitiligo and autoimmune thyroid disorders FRONTIERS IN ENDOCRINOLOGY 2017
Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line ENDOCRINE 2016
Consumption of iodized salt may not represent a reliable indicator of iodine adequacy. Evidence from a cross-sectional study on schoolchildren living in an urban area of central Italy NUTRITION 2016
Pyrazolopyrimidine derivatives as antineoplastic agents. With a special focus on thyroid cancer MINI-REVIEWS IN MEDICINAL CHEMISTRY 2016
Antineoplastic effects of PPARγ agonists, with a special focus on thyroid cancer CURRENT MEDICINAL CHEMISTRY 2016
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line INVESTIGATIONAL NEW DRUGS 2016
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer EXPERT REVIEW OF ANTICANCER THERAPY 2016
Tyrosine kinase inhibitors. Therapies for thyroid cancer Advances in Genome Science: Genes in Health and Disease 2016
Emerging therapeutic approaches for the most aggressive epithelial thyroid cancers Thyroid Cancer - Diagnosis and Therapy 2016
Aurora kinases. New molecular targets for the therapy of aggressive thyroid cancers Anti-cancer Drugs - Nature, Synthesis and Cell 2016
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients PLOS ONE 2015
Association of thyroid diseases with primary extra-thyroidal malignancies in women. Results of a cross-sectional study of 6,386 patients PLOS ONE 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma